<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-29590" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Sturge-Weber Syndrome</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Singh</surname>
            <given-names>Achint K.</given-names>
          </name>
          <aff>Un of Texas Health Sci Ctr San Antonio</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Keenaghan</surname>
            <given-names>Michael</given-names>
          </name>
          <aff>Kings County Hospital, St. Georges Uni</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Achint Singh declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Michael Keenaghan declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>1</day>
          <month>5</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-29590.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>Sturge-Weber syndrome, also known as encephalotrigeminal angiomatosis, is a neurocutaneous disorder characterized by angiomas involving the face, choroid, and leptomeninges. It is the third most common neurocutaneous syndrome after neurofibromatosis and tuberous sclerosis. This activity outlines the evaluation and management of Sturge-Weber syndrome and reviews the role of the interprofessional team in the care of patients with this condition.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Review the epidemiology of Sturge-Weber syndrome.</p></list-item><list-item><p>Describe the presentation of patients with Sturge-Weber syndrome.</p></list-item><list-item><p>Outline management considerations for Sturge-Weber syndrome.</p></list-item><list-item><p>Summarize the importance of improving care coordination amongst the interprofessional team to enhance the care of patients with Sturge-Weber syndrome and improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=29590&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=29590">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-29590.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Sturge-Weber syndrome (SWS) is a neurocutaneous syndrome characterized by angiomas involving the face, choroid, and leptomeninges. The facial capillary vascular malformation is also known as "port-wine stain" or "nevus flammeus" and usually is seen&#x000a0;in the territory of the trigeminal nerve.&#x000a0;Sturge-Weber syndrome&#x000a0;is also called encephalotrigeminal angiomatosis. It is the third most common neurocutaneous syndrome after neurofibromatosis and tuberous sclerosis.<xref ref-type="bibr" rid="article-29590.r1">[1]</xref>&#x000a0;The neurologic manifestations of SWS include atonic, tonic, or myoclonic seizures.</p>
      </sec>
      <sec id="article-29590.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Sturge-Weber syndrome is a sporadic developmental disorder caused by somatic mosaic mutations in the GNAQ gene which is located on the long arm of chromosome 9.<xref ref-type="bibr" rid="article-29590.r2">[2]</xref>&#x000a0;It has been postulated that the presence of facial and pial angiomas suggests the persistence of primordial sinusoidal vascular channels. Another possibility is that the superficial venous drainage of the brain never fully develops and the capillaries and small venous channels become dilated to compensate.</p>
      </sec>
      <sec id="article-29590.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The incidence of&#x000a0;Sturge-Weber syndrome is not well known and estimated to be 1 in 20,000-50,000 live births.&#x000a0;SWS affects males and females equally and there is no&#x000a0;race predilection.<xref ref-type="bibr" rid="article-29590.r1">[1]</xref></p>
      </sec>
      <sec id="article-29590.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>The facial nevus is composed of multiple thin-walled vessels that resemble capillaries. The neuropathological finding is an angioma that consists of multiple capillaries and small venous channels and is usually confined to the pia mater. There is a relative lack of superficial cortical veins, and the blood is shunted to the deep venous system by the enlarged medullary veins which result in stasis and ischemic changes.</p>
      </sec>
      <sec id="article-29590.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>A seizure is usually the first neurological manifestation of Sturge-Weber syndrome. Infantile spasms are seen in approximately 90% of affected&#x000a0;patients in the first year of life followed by atonic, tonic, or myoclonic seizures. Increasing hemiparesis commonly accompanies seizures. Seizures progressively become refractory to medication.<xref ref-type="bibr" rid="article-29590.r3">[3]</xref>&#x000a0;Facial nevus (port-wine stain) is another common finding and is typically seen along the ophthalmic or maxillary segment of the trigeminal nerve (forehead, cheeks). It is typically unilateral, present at birth, and does not change with the age of the patient.<xref ref-type="bibr" rid="article-29590.r4">[4]</xref>&#x000a0;This appearance is in sharp contrast to the infantile hemangioma which is more common than a port-wine stain; however, it is not present at birth. It slowly grows and is followed by involution. A child with a facial port-wine stain has a 10% to 35% risk of brain involvement. If there is involvement of both upper and lower eyelids, then the risk of glaucoma increases up to 50%. Glaucoma is almost always ipsilateral to the facial port-wine stain. Not all patients with port-wine stains have Sturge-Weber syndrome. Patients with Sturge-Weber syndrome may present with cerebral symptoms without facial&#x000a0;findings. Ocular involvement in infancy may present with increased vascularity of the conjunctiva, eye enlargement, strabismus, and increased tearing. Other symptoms are intellectual disability, early handedness, and gaze preferences. Diffuse choroidal hemangioma is seen in about 20% of patients with&#x000a0;Sturge-Weber syndrome&#x000a0;and is usually on the same side as a facial port-wine stain.<xref ref-type="bibr" rid="article-29590.r5">[5]</xref>&#x000a0;Choroidal hemangiomas grow slowly and usually do not cause any symptoms. Retina overlying the choroidal hemangioma may be normal; however, it may also show pathological changes such as epithelial atrophy/proliferation, drusen formation, or detachment.</p>
      </sec>
      <sec id="article-29590.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Diagnosis of Sturge-Weber syndrome is based on typical clinical&#x000a0;symptoms, facial appearance, and brain magnetic resonance imaging (MRI) findings.<xref ref-type="bibr" rid="article-29590.r6">[6]</xref>&#x000a0;An ophthalmic examination is required to rule out glaucoma. Ocular ultrasound can demonstrate diffuse choroidal thickening which suggests choroidal hemangioma. Gyriform calcifications can be seen on the skull radiographs and are classically described as "tram-track sign." Computed tomogram (CT) is the best modality to detect calcifications and also show the other changes such as cortical atrophy and leptomeningeal enhancement on the post-contrast studies. However, CT uses ionizing radiation, and the routine use of CT in children is not recommended. Therefore, MRI of the brain with contrast is the recommended imaging modality of choice. The most common locations are occipital and posterior parietal/temporal lobes. The MRI findings depend on the stage of the disease. In the early phase, there is transient hyperperfusion with accelerated myelin maturation, leptomeningeal enhancement (seen as serpiginous enhancement along the sulci), and restricted diffusion if there is an associated acute ischemic event. In the late phase, an increased T2 signal is seen in the region of gliosis with decreased pial enhancement and cortical atrophy. There is a lack of superficial cortical veins with prominent deep medullary/subependymal veins and enlarged choroid plexus. Gyriform calcifications are best seen on T2* or SWI (susceptibility-weighted images) and appear as areas of signal loss along the gyri in a serpentine pattern. Patients with cutaneous&#x000a0;and ocular manifestations with a normal brain MRI at one year of age are unlikely to&#x000a0;have brain involvement&#x000a0;in the future. Choroidal angiomas can be seen on MRI as increased enhancement along the posterior choroid layer of the globe. Fluorodeoxyglucose-positron emission tomography (FDG-PET) may be a useful modality to study cerebral metabolism in patients with&#x000a0;Sturge-Weber syndrome. The affected area is usually hypermetabolic in the early stages with hypometabolism in the late stage.<xref ref-type="bibr" rid="article-29590.r7">[7]</xref>&#x000a0;PET may be useful in surgical planning when cortical resection is required for the treatment of intractable seizures.</p>
      </sec>
      <sec id="article-29590.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>There is no specific treatment for Sturge-Weber syndrome. The primary aim is to minimize seizure activity with anticonvulsive medications. Surgery may be considered in patients who fail medical management and continue to have refractory seizures. The surgical procedures for Sturge-Weber syndrome include hemispherectomy or focal resection of the seizure focus. Patients with bilateral involvement are typically not good candidates for surgery.<xref ref-type="bibr" rid="article-29590.r8">[8]</xref>&#x000a0;Low-dose aspirin has also been shown to be effective in decreasing the frequency of seizures and stroke-like episodes.<xref ref-type="bibr" rid="article-29590.r9">[9]</xref>&#x000a0;An annual ophthalmologic examination is recommended even if the early evaluation does not detect glaucoma.&#x000a0;The goal of glaucoma treatment is to reduce the intraocular fluid which decreases the intraocular pressure with subsequently decreased the risk of vision loss. Topical medication is considered first for late-onset glaucoma. The surgery is considered for patients with early-onset glaucoma and associated angle abnormalities and includes goniotomy or trabeculotomy. Further surgeries such as trabeculectomy or glaucoma drainage device may be considered for resistant patients.<xref ref-type="bibr" rid="article-29590.r10">[10]</xref>&#x000a0;The port-wine stain can be treated with laser photocoagulation which results in irreversible damage to the blood vessels without damage to the other skin components.</p>
      </sec>
      <sec id="article-29590.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <list list-type="bullet">
          <list-item>
            <p>Blue rubber bleb nevus syndrome</p>
          </list-item>
          <list-item>
            <p>Klippel-Trenaunay-Weber syndrome</p>
          </list-item>
          <list-item>
            <p>PHACES (posterior fossa abnormalities, hemangiomas, arterial anomalies, cardiac, eye, and sternal anomalies)</p>
          </list-item>
          <list-item>
            <p>Wyburg-Mason syndrome</p>
          </list-item>
        </list>
        <p>Sturge-Weber syndrome can easily be differentiated from these conditions based on clinical history, physical examination, and brain MRI findings.</p>
      </sec>
      <sec id="article-29590.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis for these patients is guarded and depends on the severity of associated anomalies.<xref ref-type="bibr" rid="article-29590.r11">[11]</xref>&#x000a0;[Level 5]</p>
      </sec>
      <sec id="article-29590.s11" sec-type="Complications">
        <title>Complications</title>
        <list list-type="bullet">
          <list-item>
            <p>Seizures</p>
          </list-item>
          <list-item>
            <p>Stroke-like episodes</p>
          </list-item>
          <list-item>
            <p>Glaucoma</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-29590.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>The patient and parents should be made to understand that there is no cure for this disease and the maximum we can offer is to give symptomatic treatment and control the neurologic and ocular manifestations.</p>
      </sec>
      <sec id="article-29590.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>The management of Sturge-Weber syndrome is best accomplished with an interprofessional team approach.&#x000a0;The team may include a geneticist, pediatricians, pediatric ophthalmologists, pediatric radiologists, pediatric neurologists, nurse practitioners, and pediatric neurosurgeons. There is no cure for the syndrome and all treatments are symptom-based.&#x000a0;In addition to preventing seizures,&#x000a0;patients need ophthalmology follow-up&#x000a0;due to the risk of developing&#x000a0;glaucoma. The skin lesions&#x000a0;can be managed by a dermatologist. Nurses play an important role in patient and parent education.</p>
      </sec>
      <sec id="article-29590.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=29590&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=29590">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/skin-problems-and-treatments/sturge-weber-syndrome/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=29590">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/29590/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=29590">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-29590.s15">
        <fig id="article-29590.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Right occipital and temporal leptomeningeal enhancement with enlarged choroid plexus in a patient with Sturge-Weber syndrome. Contributed by Achint Singh</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="enlarged__choroid__pl" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-29590.s16">
        <title>References</title>
        <ref id="article-29590.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Comi</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Sturge-Weber syndrome.</article-title>
            <source>Handb Clin Neurol</source>
            <year>2015</year>
            <volume>132</volume>
            <fpage>157</fpage>
            <page-range>157-68</page-range>
            <pub-id pub-id-type="pmid">26564078</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29590.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shirley</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Tang</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Gallione</surname>
                <given-names>CJ</given-names>
              </name>
              <name>
                <surname>Baugher</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Frelin</surname>
                <given-names>LP</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>North</surname>
                <given-names>PE</given-names>
              </name>
              <name>
                <surname>Marchuk</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Comi</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Pevsner</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ.</article-title>
            <source>N Engl J Med</source>
            <year>2013</year>
            <month>May</month>
            <day>23</day>
            <volume>368</volume>
            <issue>21</issue>
            <fpage>1971</fpage>
            <page-range>1971-9</page-range>
            <pub-id pub-id-type="pmid">23656586</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29590.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pinto</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sahin</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pearl</surname>
                <given-names>PL</given-names>
              </name>
            </person-group>
            <article-title>Epileptogenesis in neurocutaneous disorders with focus in Sturge Weber syndrome.</article-title>
            <source>F1000Res</source>
            <year>2016</year>
            <volume>5</volume>
            <pub-id pub-id-type="pmid">27019697</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29590.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Enjolras</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Riche</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Merland</surname>
                <given-names>JJ</given-names>
              </name>
            </person-group>
            <article-title>Facial port-wine stains and Sturge-Weber syndrome.</article-title>
            <source>Pediatrics</source>
            <year>1985</year>
            <month>Jul</month>
            <volume>76</volume>
            <issue>1</issue>
            <fpage>48</fpage>
            <page-range>48-51</page-range>
            <pub-id pub-id-type="pmid">4011357</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29590.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mara&#x000f1;a P&#x000e9;rez</surname>
                <given-names>AI</given-names>
              </name>
              <name>
                <surname>Ruiz-Falc&#x000f3; Rojas</surname>
                <given-names>ML</given-names>
              </name>
              <name>
                <surname>Puertas Mart&#x000ed;n</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Dom&#x000ed;nguez Carral</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Carreras S&#x000e1;ez</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Duat Rodr&#x000ed;guez</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>S&#x000e1;nchez Gonz&#x000e1;lez</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>Analysis of Sturge-Weber syndrome: A retrospective study of multiple associated variables.</article-title>
            <source>Neurologia</source>
            <year>2017</year>
            <season>Jul-Aug</season>
            <volume>32</volume>
            <issue>6</issue>
            <fpage>363</fpage>
            <page-range>363-370</page-range>
            <pub-id pub-id-type="pmid">26964511</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29590.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Comi</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Update on Sturge-Weber syndrome: diagnosis, treatment, quantitative measures, and controversies.</article-title>
            <source>Lymphat Res Biol</source>
            <year>2007</year>
            <volume>5</volume>
            <issue>4</issue>
            <fpage>257</fpage>
            <page-range>257-64</page-range>
            <pub-id pub-id-type="pmid">18370916</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29590.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chugani</surname>
                <given-names>HT</given-names>
              </name>
              <name>
                <surname>Mazziotta</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Phelps</surname>
                <given-names>ME</given-names>
              </name>
            </person-group>
            <article-title>Sturge-Weber syndrome: a study of cerebral glucose utilization with positron emission tomography.</article-title>
            <source>J Pediatr</source>
            <year>1989</year>
            <month>Feb</month>
            <volume>114</volume>
            <issue>2</issue>
            <fpage>244</fpage>
            <page-range>244-53</page-range>
            <pub-id pub-id-type="pmid">2783735</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29590.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Arzimanoglou</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Andermann</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Aicardi</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sainte-Rose</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Beaulieu</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Villemure</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Olivier</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rasmussen</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Sturge-Weber syndrome: indications and results of surgery in 20 patients.</article-title>
            <source>Neurology</source>
            <year>2000</year>
            <month>Nov</month>
            <day>28</day>
            <volume>55</volume>
            <issue>10</issue>
            <fpage>1472</fpage>
            <page-range>1472-9</page-range>
            <pub-id pub-id-type="pmid">11094100</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29590.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bay</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Kossoff</surname>
                <given-names>EH</given-names>
              </name>
              <name>
                <surname>Lehmann</surname>
                <given-names>CU</given-names>
              </name>
              <name>
                <surname>Zabel</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Comi</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Survey of aspirin use in Sturge-Weber syndrome.</article-title>
            <source>J Child Neurol</source>
            <year>2011</year>
            <month>Jun</month>
            <volume>26</volume>
            <issue>6</issue>
            <fpage>692</fpage>
            <page-range>692-702</page-range>
            <pub-id pub-id-type="pmid">21427442</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29590.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Thavikulwat</surname>
                <given-names>AT</given-names>
              </name>
              <name>
                <surname>Edward</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>AlDarrab</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Vajaranant</surname>
                <given-names>TS</given-names>
              </name>
            </person-group>
            <article-title>Pathophysiology and management of glaucoma associated with phakomatoses.</article-title>
            <source>J Neurosci Res</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>97</volume>
            <issue>1</issue>
            <fpage>57</fpage>
            <page-range>57-69</page-range>
            <pub-id pub-id-type="pmid">29607552</pub-id>
          </element-citation>
        </ref>
        <ref id="article-29590.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Higueros</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Roe</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Granell</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Baselga</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Sturge-Weber Syndrome: A Review.</article-title>
            <source>Actas Dermosifiliogr</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>108</volume>
            <issue>5</issue>
            <fpage>407</fpage>
            <page-range>407-417</page-range>
            <pub-id pub-id-type="pmid">28126187</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
